FAP and glioblastoma: Therefore, we summarized the recent progress in FAP expression profiling and in the understanding of the biological processes in GBM and discussed the potential of FAP as an imaging and prognostic biomarker and therapeutic target for remodeling the immunosuppressive microenvironment and reverting TMZ resistance.